Paper40100580
Development and validation of M2 macrophage-related genes in a prognostic model of lung adenocarcinoma based on bulk RNA and ScRNA datasets.
Wang B and 5 others. Discov Oncol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Development and validation of M2 macrophage-related genes in a prognostic model of lung adenocarcinoma based on bulk RNA and ScRNA datasets. Papers, record 40100580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40100580
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development and validation of M2 macrophage-related genes in a prognostic model of lung adenocarcinoma based on bulk RNA and ScRNA datasets.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2463P023 | Key Laboratory for Pulmonary Nodule Diagnosis and Treatment in Baoding | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27095226 | Selenoproteins: Antioxidant selenoenzymes and beyond. | Arch Biochem Biophys | 2016 | https://conductscience.org/library/papers/27095226 | PubMed |
| 2 | 31831780 | Caveolin-2 deficiency induces a rapid anti-tumor immune response prior to regression of implanted murine lung carcinoma tumors. | Sci Rep | 2019 | https://conductscience.org/library/papers/31831780 | PubMed |
| 3 | 8971064 | Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | JAMA | 1996 | https://conductscience.org/library/papers/8971064 | PubMed |
| 4 | 9835626 | In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9835626 | PubMed |
| 5 | 38013279 | Identification of metabolism-related gene signature in lung adenocarcinoma. | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/38013279 | PubMed |
| 6 | 31443242 | TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31443242 | PubMed |
| 7 | 30288056 | CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30288056 | PubMed |
| 8 | 26667336 | Lung Cancer Statistics. | Adv Exp Med Biol | 2016 | https://conductscience.org/library/papers/26667336 | PubMed |
| 9 | 37559628 | Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma. | J Thorac Dis | 2023 | https://conductscience.org/library/papers/37559628 | PubMed |
| 10 | 26366732 | TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2. | PLoS One | 2015 | https://conductscience.org/library/papers/26366732 | PubMed |
| 11 | 35711936 | Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma. | Front Genet | 2022 | https://conductscience.org/library/papers/35711936 | PubMed |
| 12 | 31036057 | Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31036057 | PubMed |
| 13 | 10066077 | Matrix metalloproteinase inhibitors. | Breast Cancer Res Treat | 1998 | https://conductscience.org/library/papers/10066077 | PubMed |
| 14 | 33829674 | Improved trends of lung cancer mortality-to-incidence ratios in countries with high healthcare expenditure. | Thorac Cancer | 2021 | https://conductscience.org/library/papers/33829674 | PubMed |
| 15 | 36142328 | TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142328 | PubMed |
| 16 | 35399247 | Machine learning-based screening of the diagnostic genes and their relationship with immune-cell infiltration in patients with lung adenocarcinoma. | J Thorac Dis | 2022 | https://conductscience.org/library/papers/35399247 | PubMed |
| 17 | 37657358 | Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. | Comput Biol Med | 2023 | https://conductscience.org/library/papers/37657358 | PubMed |
| 18 | 20371344 | Macrophage diversity enhances tumor progression and metastasis. | Cell | 2010 | https://conductscience.org/library/papers/20371344 | PubMed |
| 19 | 33195410 | Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/33195410 | PubMed |
| 20 | 35517414 | CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells. | J Cancer | 2022 | https://conductscience.org/library/papers/35517414 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41618295 | GJB2 drives LUAD progression in part via cAMP-mediated M2 macrophage polarization through the PKA-CREB pathway. | Respir Res | 2026 | https://conductscience.org/library/papers/41618295 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAV2 | 858 | PubTator's text mining | https://conductscience.org/library/genes/858 | NCBI Gene |
| MIF | 4282 | PubTator's text mining | https://conductscience.org/library/genes/4282 | NCBI Gene |
| SELENBP1 | 8991 | PubTator's text mining | https://conductscience.org/library/genes/8991 | NCBI Gene |
| TIMP1 | 7076 | PubTator's text mining | https://conductscience.org/library/genes/7076 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40100580
GET https://conductscience.org/api/papers/v1/40100580/references?page=2